Publication | Closed Access

Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts

NanoparticlesNanomedicineHyaluronic Acid NanoparticlesEngineeringTherapeutic NanomaterialsPolymer-drug ConjugateNano-drug DeliveryTumor TargetingBiomedical EngineeringActive TargetingMatrix BiologyIntelligent DeliveryRadiation Oncology